dc.contributor.author |
Tsopelas, F |
en |
dc.contributor.author |
Tsantili-Kakoulidou, A |
en |
dc.contributor.author |
Ochsenkuhn-Petropoulou, M |
en |
dc.date.accessioned |
2014-03-01T01:32:57Z |
|
dc.date.available |
2014-03-01T01:32:57Z |
|
dc.date.issued |
2010 |
en |
dc.identifier.issn |
1618-2642 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/20246 |
|
dc.subject |
Biomimetic chromatography |
en |
dc.subject |
Human serum albumin/α1-acid glycoprotein columns |
en |
dc.subject |
Immobilized artificial membrane chromatography |
en |
dc.subject |
Oral absorption |
en |
dc.subject |
Plasma protein binding |
en |
dc.subject |
Selenium speciation |
en |
dc.subject.classification |
Biochemical Research Methods |
en |
dc.subject.classification |
Chemistry, Analytical |
en |
dc.subject.other |
Buffer composition |
en |
dc.subject.other |
DL-methionine |
en |
dc.subject.other |
Electrostatic interactions |
en |
dc.subject.other |
Human serum albumins |
en |
dc.subject.other |
Immobilized artificial membrane chromatographies |
en |
dc.subject.other |
Immobilized artificial membranes |
en |
dc.subject.other |
Mobile phase conditions |
en |
dc.subject.other |
Octanol-water partitioning |
en |
dc.subject.other |
Oral absorption |
en |
dc.subject.other |
Pharmacokinetic properties |
en |
dc.subject.other |
Phosphate-buffered salines |
en |
dc.subject.other |
Plasma protein |
en |
dc.subject.other |
Plasma protein binding |
en |
dc.subject.other |
Retention behavior |
en |
dc.subject.other |
Retention factors |
en |
dc.subject.other |
Selenides |
en |
dc.subject.other |
Selenium speciation |
en |
dc.subject.other |
Selenocystamine |
en |
dc.subject.other |
Selenocystine |
en |
dc.subject.other |
Selenourea |
en |
dc.subject.other |
Stationary phasis |
en |
dc.subject.other |
Absorption |
en |
dc.subject.other |
Acids |
en |
dc.subject.other |
Biochemistry |
en |
dc.subject.other |
Body fluids |
en |
dc.subject.other |
Chromatographic analysis |
en |
dc.subject.other |
Drug products |
en |
dc.subject.other |
Glycoproteins |
en |
dc.subject.other |
Imaging techniques |
en |
dc.subject.other |
Liquid chromatography |
en |
dc.subject.other |
Plasmas |
en |
dc.subject.other |
Proteins |
en |
dc.subject.other |
Radiation protection |
en |
dc.subject.other |
Selenium |
en |
dc.subject.other |
Selenium compounds |
en |
dc.subject.other |
Biomimetics |
en |
dc.subject.other |
organoselenium derivative |
en |
dc.subject.other |
orosomucoid |
en |
dc.subject.other |
selenic acid |
en |
dc.subject.other |
selenium |
en |
dc.subject.other |
selenium derivative |
en |
dc.subject.other |
serum albumin |
en |
dc.subject.other |
sodium selenite |
en |
dc.subject.other |
absorption |
en |
dc.subject.other |
article |
en |
dc.subject.other |
artificial membrane |
en |
dc.subject.other |
biological model |
en |
dc.subject.other |
biomimetics |
en |
dc.subject.other |
chemistry |
en |
dc.subject.other |
human |
en |
dc.subject.other |
liquid chromatography |
en |
dc.subject.other |
methodology |
en |
dc.subject.other |
Absorption |
en |
dc.subject.other |
Biomimetics |
en |
dc.subject.other |
Chromatography, Liquid |
en |
dc.subject.other |
Humans |
en |
dc.subject.other |
Membranes, Artificial |
en |
dc.subject.other |
Models, Biological |
en |
dc.subject.other |
Organoselenium Compounds |
en |
dc.subject.other |
Orosomucoid |
en |
dc.subject.other |
Selenium |
en |
dc.subject.other |
Selenium Compounds |
en |
dc.subject.other |
Serum Albumin |
en |
dc.subject.other |
Sodium Selenite |
en |
dc.title |
Biomimetic chromatographic analysis of selenium species: Application for the estimation of their pharmacokinetic properties |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1007/s00216-010-3624-9 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1007/s00216-010-3624-9 |
en |
heal.language |
English |
en |
heal.publicationDate |
2010 |
en |
heal.abstract |
The retention behavior of selenites, selenates, seleno-dl-methionine, selenocystine, selenocystamine, selenourea, dimethyl selenide, and dimethyl diselenide was investigated by means of biomimetic liquid chromatography. For this purpose, two immobilized artificial membrane (IAM) columns, namely, IAM.PC.DD2 and IAM.PC.MG, and two immobilized plasma protein columns, human serum albumin (HSA) and α1-acid glycoprotein (AGP) columns, were employed using different mobile phase conditions in respect to pH and buffer composition. In general, satisfactory interrelations between retention factors obtained with the two IAM stationary phases and HSA/AGP columns were obtained. Large differences were observed between biomimetic retention factors and octanol-water logD values, since the latter fail to describe electrostatic interactions. In contrast, despite the column diversity, the net retention outcome on all four biomimetic columns was quite similar, especially in the presence of phosphate-buffered saline, which by its effective shielding alleviates the differences between the stationary phases. Of the two IAM columns, IAM.PC.DD2 showed better performance when compared with HSA and AGP columns as well as to octanol-water partitioning. Biomimetic chromatographic indices were further used to estimate the percentage of human oral absorption and plasma protein binding of the eight selenium species investigated, according to equations previously reported in the literature. The estimated values of human oral absorption imply moderate absorption only for dimethyl diselenide, which also may exhibit considerable plasma protein binding. Moderate affinity for plasma proteins should also be expected for dimethyl selenide and selenocystamine. © 2010 Springer-Verlag. |
en |
heal.publisher |
SPRINGER HEIDELBERG |
en |
heal.journalName |
Analytical and Bioanalytical Chemistry |
en |
dc.identifier.doi |
10.1007/s00216-010-3624-9 |
en |
dc.identifier.isi |
ISI:000279453000018 |
en |
dc.identifier.volume |
397 |
en |
dc.identifier.issue |
6 |
en |
dc.identifier.spage |
2171 |
en |
dc.identifier.epage |
2180 |
en |